Form 8-K - Current report:
SEC Accession No. 0001641172-25-004562
Filing Date
2025-04-14
Accepted
2025-04-14 16:05:18
Documents
14
Period of Report
2025-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39770
  Complete submission text file 0001641172-25-004562.txt   259014

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE biaf-20250412.xsd EX-101.SCH 3785
3 XBRL DEFINITION FILE biaf-20250412_def.xml EX-101.DEF 26626
4 XBRL LABEL FILE biaf-20250412_lab.xml EX-101.LAB 36673
5 XBRL PRESENTATION FILE biaf-20250412_pre.xml EX-101.PRE 25250
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5815
Mailing Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217
Business Address 3300 NACOGDOCHES ROAD SUITE 216 SAN ANTONIO TX 78217 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

EIN.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 25836049
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)